MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment. [electronic resource]
Producer: 20180226Description: 431-438 p. digitalISSN:- 1432-1335
- Adenocarcinoma -- diagnosis
- Adenocarcinoma of Lung
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Pharmacological -- metabolism
- Biomarkers, Tumor -- genetics
- Cisplatin -- administration & dosage
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Humans
- Lung Neoplasms -- diagnosis
- Male
- MicroRNAs -- genetics
- Oligonucleotide Array Sequence Analysis
- Prognosis
- Transcriptome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.